A20 plays an antitumor role in hepatocellular carcinomas [39] and lymphoma [43], whereas A20 overexpression facilitates the proliferation of glioma and bladder cancers [44,45] and ALL cells [13]. This evidence concerns the gene TNFAIP3 and lymphoma.